Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pol Darras

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 14, 2018
Nonfasting lipid testing: the new standard for cardiovascular risk assessmentPol Darras, Andre Mattman, Gordon A Francis
Journal of Hypertension|May 31, 2019
ReplyGregory A Kline, Pol Darras, Alexander Leung, et al.
Journal of Hypertension|February 1, 2019
Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronismGregory A Kline, Pol Darras, Alexander A Leung, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 14, 2018
Nonfasting lipid testing: the new standard for cardiovascular risk assessmentPol Darras, Andre Mattman, Gordon A Francis
Journal of Hypertension|May 31, 2019
ReplyGregory A Kline, Pol Darras, Alexander Leung, et al.
Journal of Hypertension|February 1, 2019
Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronismGregory A Kline, Pol Darras, Alexander A Leung, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Pageof 1